ngs provides improved identification of uncommon egfr mutations over pcr in nsclc
Published 2 years ago • 135 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
1:21
detectability of uncommon egfr mutations in nsclc: ngs versus pcr
-
0:42
ngs vs pcr for egfr genotyping in nsclc
-
2:45
activity of egfr tkis in patients with nsclc with uncommon egfr mutations
-
0:37
response to systemic anti-cancer therapy in uncommon egfr mutations
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
1:04
molecular testing in egfr mutant driven nsclc
-
38:04
blood-based detection: egfr/ kras mutations for nsclc patients using multiplexed droplet digital pcr
-
1:13
identification of egfr mutations impact overall prognosis in lung cancers
-
56:19
detection of egfr mutations in plasma cfdna and ctcs of nsclc patients using crystal digital pcr™
-
43:43
webinar: going beyond egfr: evaluating technologies for molecular genetic testing in nsclc
-
4:41
egfr exon-20 mutation - lung cancer video library
-
1:05:12
new horizons in egfr-mutated nsclc: broadening the impact of precision testing
-
47:10
ascp project echo® videoconference: key actionable driver mutations in patients with advanced nsclc
-
12:11
clinical clips in nsclc harboring egfr mutations: cutting-edge reports from asco 2024
-
3:14
advancements of targeted therapy for egfr mutations in nsclc
-
22:49
grace targeted therapies lung cancer 2021 - management of uncommon egfr mutations including exon 20
-
2:21
treatment of egfr nsclc after progression
-
2:57
egfr mutations increase recurrence in nsclc
-
2:26
egfr mutations in nsclc